The information contained in the Patient in Publications Training Course and on the WECAN website has been derived from sources believed to be reliable and is correct to the best of the publisher’s knowledge and capacity.
WECAN accepts no liability (including liability for negligence) for any loss or damage (including the consequential or indirect loss or damage) that may arise in any way from access to, use of, or inability to use this resource or any material contained in it.
As a student, you are advised to verify all relevant representations, statements, and information.
The entire risk arising out of the use of the materials presented in the Patient in Publications training course and on the WECAN website are distributed as an information source only.
Any information provided is for the purpose of general guidance.
WECAN makes no guarantees that you will obtain a particular outcome.
Finally, these courses are NOT designed for people who want to create and sell courses.
License and Copyright
The ‘Patients in Publications’ Training Course by WECAN (https://wecanadvocate.eu) and Envision Pharma Group (https://www.envisionpharmagroup.com/) is provided under the Creative Commons License (CC BY 4.0). This license means you are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially
without express written persmission, but under the following terms:
- You must give This includes the name of WECAN and Envision The Patient as creators, a link to the CC BY 4.0 license, a copyright notice, a license note, a disclaimer notice, and a link to the original material (https://wecanadvocate.eu/patients-in-publications)
- You must . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not apply legal terms or technological measures (e.g. access restrictions) that legally restrict others from doing anything the license permits.
We ask that you give credits to WECAN and Envision Pharma Group when using materials from this training course.